Return to homepagePandemic Pact

Baxalta Innovations GmbH (Takeda)

  • Funded by Austrian Research Promotion Agency (FFG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Austrian Research Promotion Agency (FFG)

  • Principal Investigator

    N/A

  • Research Location

    Austria

  • Lead Research Institution

    Baxalta Innovations GmbH (Takeda)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of a possible antibody therapy for COVID-19. It is a medicine with the potential to treat people with serious complications from COVID-19. (also area of ​​innovative manufacturing technologies)